|
FR2556219B1
(fr)
|
1983-12-07 |
1987-06-26 |
Merieux Inst |
Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
|
|
US5426641A
(en)
|
1994-01-28 |
1995-06-20 |
Bell Communications Research, Inc. |
Adaptive class AB amplifier for TDMA wireless communications systems
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
AU3804397A
(en)
|
1996-06-14 |
1998-01-07 |
Smithkline Beecham Corporation |
Hexameric fusion proteins and uses therefor
|
|
US20090074839A1
(en)
|
1997-01-22 |
2009-03-19 |
Marton Milankovits |
Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
WO2001045746A2
(en)
|
1999-12-24 |
2001-06-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20050089932A1
(en)
|
2001-04-26 |
2005-04-28 |
Avidia Research Institute |
Novel proteins with targeted binding
|
|
WO2005077981A2
(en)
|
2003-12-22 |
2005-08-25 |
Xencor, Inc. |
Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
|
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
|
GB0614780D0
(en)
|
2006-07-25 |
2006-09-06 |
Ucb Sa |
Biological products
|
|
WO2008088422A2
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
BRPI0620639A2
(pt)
|
2006-12-21 |
2011-11-22 |
Micromet Ag |
anticorpos de cadeia simples biespecìficos e composição farmacêutica compreendendo os mesmos
|
|
US20080260738A1
(en)
|
2007-04-18 |
2008-10-23 |
Moore Margaret D |
Single chain fc, methods of making and methods of treatment
|
|
BRPI0811857A2
(pt)
|
2007-05-14 |
2014-10-21 |
Biogen Idec Inc |
Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados.
|
|
EP2185589B1
(en)
|
2007-06-01 |
2016-01-06 |
University of Maryland, Baltimore |
Immunoglobulin constant region fc receptor binding agents
|
|
PT2235064E
(pt)
|
2008-01-07 |
2016-03-01 |
Amgen Inc |
Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática
|
|
SG189730A1
(en)
|
2008-04-02 |
2013-05-31 |
Macrogenics Inc |
Her2/neu-specific antibodies and methods of using same
|
|
WO2010042481A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
|
US20100143353A1
(en)
|
2008-12-04 |
2010-06-10 |
Mosser David M |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
|
|
CA2747011C
(en)
*
|
2008-12-18 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Nkg2d-fc for immunotherapy
|
|
AU2010206681A1
(en)
|
2009-01-23 |
2011-09-01 |
Biogen Idec Ma Inc. |
Stabilized Fc polypeptides with reduced effector function and methods of use
|
|
WO2010135534A2
(en)
|
2009-05-20 |
2010-11-25 |
Children's Medical Center Corporation |
Compositions for the treatment of metastatic cancer and methods of use thereof
|
|
EP2432803A2
(en)
|
2009-05-20 |
2012-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
JP5683581B2
(ja)
|
2009-06-30 |
2015-03-11 |
リサーチ ディベロップメント ファウンデーション |
免疫グロブリンＦｃポリペプチド
|
|
CA2781519A1
(en)
|
2009-09-16 |
2011-03-24 |
Genentech, Inc. |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
KR101808602B1
(ko)
|
2009-10-07 |
2017-12-13 |
마크로제닉스, 인크. |
푸코실화 정도의 변경으로 인해 개선된 이펙터 기능을 나타내는 Ｆｃ 영역-함유 폴리펩티드, 그것의 사용 방법
|
|
EP2504360B1
(en)
|
2009-11-23 |
2018-08-15 |
Amgen Inc. |
Monomeric antibody fc
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
JP6200806B2
(ja)
|
2010-05-21 |
2017-09-20 |
メリマック ファーマシューティカルズ インコーポレーティッド |
二重特異的融合タンパク質
|
|
WO2012006635A1
(en)
|
2010-07-09 |
2012-01-12 |
Biogen Idec Hemophilia Inc. |
Processable single chain molecules and polypeptides made using same
|
|
MX368531B
(es)
|
2010-07-28 |
2019-10-07 |
Gliknik Inc |
Proteinas de fusion de fragmentos de proteinas humanas naturales para crear composiciones de fc de inmunoglobulinas multimerizadas ordenadamente.
|
|
US20130177555A1
(en)
|
2010-08-13 |
2013-07-11 |
Medimmune Limited |
Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use
|
|
RU2604490C2
(ru)
|
2010-11-05 |
2016-12-10 |
Займворкс Инк. |
ДИЗАЙН УСТОЙЧИВОГО ГЕТЕРОДИМЕРНОГО АНТИТЕЛА С МУТАЦИЯМИ В Fc ДОМЕНЕ
|
|
BR112013023653A2
(pt)
|
2011-03-17 |
2016-12-13 |
Univ Ramot |
anticorpo biespecífico, método de preparação do anticorpo, e composição farmacêutica
|
|
SG10201602371VA
(en)
|
2011-03-25 |
2016-04-28 |
Glenmark Pharmaceuticals Sa |
Hetero-dimeric immunoglobulins
|
|
CA2875246A1
(en)
|
2012-06-08 |
2013-12-12 |
Biogen Idec Ma Inc. |
Procoagulant compounds
|
|
WO2013192131A1
(en)
|
2012-06-21 |
2013-12-27 |
Indiana University Research And Technology Corporation |
Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function
|
|
WO2014031646A2
(en)
|
2012-08-20 |
2014-02-27 |
Gliknik Inc. |
Molecules with antigen binding and polyvalent fc gamma receptor binding activity
|
|
CN110894231A
(zh)
|
2012-10-17 |
2020-03-20 |
康诺贝林伦瑙有限公司 |
免疫调节蛋白
|
|
CN104558194B
(zh)
|
2013-10-17 |
2018-04-27 |
泰州迈博太科药业有限公司 |
一类抗CD20-Flex双功能融合蛋白、其制备方法及用途
|
|
JP2016538283A
(ja)
*
|
2013-11-13 |
2016-12-08 |
ザイムワークス，インコーポレイテッド |
Ｅｇｆｒ及び／またはｈｅｒ２を標的にする一価抗原結合性構築物及びその使用
|
|
CN106029087A
(zh)
|
2013-12-20 |
2016-10-12 |
印第安纳大学研究及科技有限公司 |
脂质化肠降血糖素受体配体人免疫球蛋白fc区融合多肽
|
|
CA2931979A1
(en)
*
|
2014-01-15 |
2015-07-23 |
F. Hoffmann-La Roche Ag |
Fc-region variants with modified fcrn-binding properties
|
|
BR112016016416A2
(pt)
|
2014-01-15 |
2017-10-03 |
Hoffmann La Roche |
VARIANTES DE REGIÕES-"Fc" COM 'FcRn' MODIFICADAS E PROPRIEDADES DE LIGAÇÃO DE PROTEÍNA "A" MANTIDAS
|
|
AU2015226101B2
(en)
|
2014-03-05 |
2019-08-22 |
Ucb Biopharma Sprl |
Multimeric Fc proteins
|
|
BR112016020368A2
(pt)
|
2014-03-05 |
2018-01-23 |
Ucb Biopharma Sprl |
proteínas fc multiméricas
|
|
AU2015248785A1
(en)
|
2014-04-16 |
2016-11-24 |
Ucb Biopharma Sprl |
Multimeric Fc proteins
|
|
CN106661125B
(zh)
|
2014-05-02 |
2021-10-01 |
动量制药公司 |
涉及工程化Fc构建体的组合物和方法
|
|
NZ726520A
(en)
|
2014-05-29 |
2018-12-21 |
Macrogenics Inc |
Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof
|
|
US12391759B2
(en)
*
|
2016-03-02 |
2025-08-19 |
Momenta Pharmaceuticals, Inc. |
Methods related to engineered Fc constructs
|
|
KR102635635B1
(ko)
|
2016-05-23 |
2024-02-14 |
모멘타 파머슈티컬스 인코포레이티드 |
유전자 조작 Fc 작제물에 관한 조성물 및 방법
|
|
CN110650748B
(zh)
|
2017-01-06 |
2024-01-02 |
动量制药公司 |
与经工程改造的Fc构建体相关的组合物和方法
|